Sort
15,440 grants matching “organoids”
Unravelling MyD88-dependent and independent mucosal immunity to Toxoplasma
$439,698Eric Y Denkers · University Of New Mexico · R01 · FY2024 · AI
Elucidating the cellular mechanisms of a pro-regenerative drug therapy for acute kidney injury
$439,684Neil A Hukriede · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · DK
Engineered hybrid aging model for disease progression
$439,567Pinar Zorlutuna · University Of Notre Dame · R01 · FY2024 · CA
Deciphering the tumor suppressive functions of macroH2A
$439,563Emily Bernstein · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · CA
Discovery of apoE4 modulators for Alzheimerâs disease therapy
$439,375Yonghe Li · Mayo Clinic Jacksonville · R01 · FY2024 · AG
Discovery of apoE4 modulators for Alzheimerâs disease therapy
$439,375Yonghe Li · Mayo Clinic Jacksonville · R01 · FY2023 · AG
Assessment of strategies for targeting transcriptional co-activators in colorectal cancer
$439,367Kurt Fisher · University Of Nebraska Medical Center · R37 · FY2024 · CA
Defining Response and Resistance to PI3K and AR inhibition in Prostate Cancer
$439,351Brett Stewart Carver · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
Defining Response and Resistance to PI3K and AR inhibition in Prostate Cancer
$439,351Brett Stewart Carver · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA
Defining Response and Resistance to PI3K and AR inhibition in Prostate Cancer
$439,351Brett Stewart Carver · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Defining Response and Resistance to PI3K and AR inhibition in Prostate Cancer
$439,351Brett Stewart Carver · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
Role of cholinergic neuroimmune signaling pathway disruption in the pathogenesis of Hirschsprung-associated enterocolitis
$439,216Ryo Hotta · Massachusetts General Hospital · R21 · FY2025 · AI
Probing the role of epigenomics in Brca1-deficient mammary tumors.
$439,200Camila Dos Santos · Cold Spring Harbor Laboratory · R01 · FY2020 · CA
Probing the role of epigenomics in Brca1-deficient mammary tumors.
$439,200Camila Dos Santos · Cold Spring Harbor Laboratory · R01 · FY2021 · CA
Transcriptional control of gut epithelial homeostasis and regeneration
$439,177Ramesh A Shivdasani · Dana-Farber Cancer Inst · R01 · FY2021 · DK
Transcriptional control of gut epithelial homeostasis and regeneration
$439,177Ramesh A Shivdasani · Dana-Farber Cancer Inst · R01 · FY2020 · DK
Transcriptional control of gut epithelial homeostasis and regeneration
$439,177Ramesh A Shivdasani · Dana-Farber Cancer Inst · R01 · FY2022 · DK
Core 2: Biospecimen/Pathology Core
$439,158Lakshmi Priya Kunju · University Of Michigan At Ann Arbor · P50 · FY2025 · CA
Intestinal epithelial cell exfoliation by caspases
$439,090Edward A Miao · Duke University · R01 · FY2020 · AI
Formation of a Novel SARS-CoV-2 Nucleocapsid Dimer: Impacts on Viral and Cellular Processes
$438,983Emily A. Bruce · University Of Vermont & St Agric College · R21 · FY2025 · AI
Collagen remodeling and tumor progression
$438,845Valerie Marie Weaver · University Of California, San Francisco · R01 · FY2010 · CA
The Metabolic Regulation of Melanoma Metastasis
$438,803Sean J Morrison · Ut Southwestern Medical Center · U01 · FY2021 · CA
Viscotaxis: Novel cell migration mechanisms regulated by microenvironmental viscosity
$438,793Konstantinos Konstantopoulos · Johns Hopkins University · R01 · FY2024 · CA
Mechanistic and Therapeutic Studies of GPR124/RECK/WNT7-Regulated Blood-Brain Barrier Function
$438,772Calvin J Kuo · Stanford University · R01 · FY2024 · NS
Diet induced modifications of microbiota metabolites in colon tumorigenesis
$438,596Robert Stephen Chapkin · Texas A&M Agrilife Research · R01 · FY2016 · CA